Investing Ideas
/
Danish Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Danish Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.

11 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
GUBRA Gubra	DKK 728.00	7.4%	487.1%	DKK 11.9b	n/a	PS53x	n/a	0%
GMAB Genmab	DKK 1,486.50	-3.2%	-29.5%	DKK 94.4b	DKK 2,340.18	PE20.1x	E23.5%	n/a
BAVA Bavarian Nordic	DKK 198.95	-0.6%	16.9%	DKK 15.6b	DKK 319.50	PE14x	E3.6%	n/a
ALK B ALK-Abelló	DKK 161.50	3.9%	61.3%	DKK 35.7b	DKK 185.17	PE45.5x	E21.5%	0%
BIOPOR BioPorto	DKK 1.58	-8.1%	-28.1%	DKK 679.7m	DKK 3.00	PS19.5x	E-27.8%	n/a
STRAP Strategic Partners	DKK 878.00	-7.6%	-32.5%	DKK 36.6m	n/a	PB2.3x	n/a	n/a
CHEMM ChemoMetec	DKK 483.00	-4.5%	19.6%	DKK 8.4b	DKK 545.00	PE61.7x	E17.2%	0.8%
HLUN B H. Lundbeck	DKK 41.16	-2.9%	27.5%	DKK 39.2b	DKK 50.14	PE15.2x	E8.8%	1.7%
STENO Stenocare	DKK 1.55	0.6%	-46.6%	DKK 31.0m	n/a	PS13.9x	n/a	n/a
ZEAL Zealand Pharma	DKK 802.50	4.9%	115.7%	DKK 56.7b	DKK 1,017.92	PS737.5x	E47.3%	n/a
NOVO B Novo Nordisk	DKK 771.60	-2.4%	11.0%	DKK 3.4t	DKK 944.92	PE36x	E14.3%	1.3%

Page 1 of 1